Prescription weight-loss medications are not a single type of treatment. They act through different biological pathways, come in oral and injectable forms, follow different schedules, and have different contraindications, warnings, and common side effects. Even medications that influence appetite do not necessarily work in the same way.
This guide offers a high-level comparison of medicines the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) identifies for long-term weight management in the United States [1]. It does not rank medications or identify a "best" choice. That decision requires an individualized evaluation by a qualified healthcare professional.
What These Medications Have in Common
Long-term weight-management medications are generally used together with nutrition and physical-activity changes, not as substitutes for them. Depending on the product, FDA labeling may cover adults with obesity or adults with overweight plus at least one weight-related condition. The exact indication, age range, dosage, and safety information are product-specific [1][2][3].
Average results from clinical trials cannot predict an individual's response. NIDDK notes that a clinician may consider whether a person loses enough weight after taking the full dose for a defined period, but stopping or changing treatment should be a shared decision rather than an unsupervised one [1].
Major Medication Categories
GLP-1 and GIP/GLP-1 medicines
Liraglutide and semaglutide activate the GLP-1 receptor. Tirzepatide activates both GIP and GLP-1 receptors. These pathways affect appetite and food intake and also have effects on blood glucose. Liraglutide is injected daily; tirzepatide is injected weekly. Current Wegovy labeling includes a weekly injection and a daily oral tablet [1][2][3].
Gastrointestinal effects such as nausea, diarrhea, vomiting, constipation, and abdominal symptoms are common in current Wegovy and Zepbound prescribing information. Both labels also include a boxed warning related to thyroid C-cell tumors observed in rodents and list specific contraindications and warnings [2][3].
Combination tablets that affect appetite pathways
Phentermine-topiramate combines a sympathomimetic medicine with an antiseizure medicine. Naltrexone-bupropion combines an opioid antagonist with an antidepressant medicine. Both are oral treatments, but their safety considerations differ. For example, NIDDK notes that phentermine-topiramate should not be used during pregnancy and that naltrexone-bupropion may not be appropriate for people with uncontrolled high blood pressure, seizures, or use of certain opioid medicines [1].
Orlistat
Orlistat works in the digestive tract by reducing absorption of some dietary fat. It is taken orally with meals and can cause gastrointestinal effects. Because it can affect absorption of fat-soluble vitamins and interact with some medicines, the complete labeling and a person's medication list matter [1]. A lower-dose version is sold without a prescription, but that does not make it appropriate for everyone.
Questions That Reveal Meaningful Differences
- What pathway does it affect? Appetite signaling, nutrient absorption, and combined central nervous system pathways are not interchangeable.
- How is it taken? Options include tablets and injections, with schedules ranging from daily to weekly.
- What health history changes the decision? Pregnancy, blood pressure, seizure history, endocrine history, gastrointestinal disease, kidney or gallbladder problems, mental-health history, and other factors may be relevant depending on the medicine.
- Could it interact with current medicines? A clinician and pharmacist need a complete list that includes prescriptions, nonprescription products, and supplements.
- What monitoring and follow-up are expected? Dose escalation, side-effect checks, laboratory testing, and response assessment vary.
- What will it cost over time? Coverage, prior authorization, copays, deductibles, pharmacy choice, and program fees can change the real cost.
The same active ingredient may be sold under different brand names for different labeled uses. A diabetes product and a weight-management product are not automatically interchangeable. Confirm the exact product, active ingredient, dose, indication, and dispensing pharmacy [1][2][3].
How a Clinician May Approach the Choice
NIDDK advises that healthcare professionals may weigh expected benefits, possible side effects, current health conditions, other medicines, family medical history, and cost [1]. Practical preferences also matter: some people may not want injections, while others may find a weekly schedule easier than a daily one. Those preferences still have to fit within safe and appropriate prescribing.
A reasonable discussion also includes what success would mean, how response will be assessed, which symptoms require prompt attention, and what the plan would be if the medicine is ineffective, unavailable, unaffordable, or poorly tolerated.
Frequently Asked Questions
Is the medicine with the greatest average trial result always the best choice?
No. Trial averages do not account for an individual's contraindications, side effects, other medicines, preferences, coverage, or response. Safety and appropriateness come before a simple ranking.
Are all prescription weight-loss medicines GLP-1 medications?
No. FDA-approved long-term options also include medicines that affect appetite through other pathways and orlistat, which acts in the digestive tract [1].
Can treatment be stopped as soon as a goal is reached?
Do not stop a prescription without discussing it with the prescriber. NIDDK notes that weight regain is common after stopping weight-management medication, and an appropriate long-term plan depends on the individual [1].
Preparing for an Appointment
Bring a complete medication and supplement list, relevant diagnoses, previous treatment experiences, insurance information, and questions about follow-up. Our questions to ask before prescription treatment and prior authorization guide can help organize that conversation.
This article provides general education, not diagnosis or treatment. Only a qualified healthcare professional who knows your medical history can determine whether a prescription medicine is appropriate.